ASX:SHL (Australia)
Business Description
Sonic Healthcare Ltd
NAICS : 621511
SIC : 8071
225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centres in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.23 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | 1.15 | |||||
| Interest Coverage | 26.19 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.52 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.1 | |||||
| 3-Year EBITDA Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 34.5 | |||||
| 3-Year FCF Growth Rate | 49.7 | |||||
| 3-Year Book Growth Rate | 10.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | -2.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.46 | |||||
| 9-Day RSI | 54.92 | |||||
| 14-Day RSI | 54.88 | |||||
| 6-1 Month Momentum % | -14.02 | |||||
| 12-1 Month Momentum % | -18.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 1.05 | |||||
| Cash Ratio | 0.37 | |||||
| Days Inventory | 55.59 | |||||
| Days Sales Outstanding | 47.35 | |||||
| Days Payable | 173.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.72 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| 3-Year Dividend Growth Rate | 3.7 | |||||
| Forward Dividend Yield % | 2.29 | |||||
| 5-Year Yield-on-Cost % | 3.34 | |||||
| 3-Year Average Share Buyback Ratio | -4 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.4 | |||||
| Operating Margin % | 23.5 | |||||
| Net Margin % | 16.14 | |||||
| ROE % | 22.81 | |||||
| ROA % | 12.25 | |||||
| ROIC % | 14.62 | |||||
| ROC (Joel Greenblatt) % | 84.33 | |||||
| ROCE % | 21.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.51 | |||||
| Forward PE Ratio | 19.65 | |||||
| PE Ratio without NRI | 11.75 | |||||
| Shiller PE Ratio | 28.33 | |||||
| Price-to-Owner-Earnings | 10.13 | |||||
| PEG Ratio | 0.66 | |||||
| PS Ratio | 1.86 | |||||
| PB Ratio | 2.37 | |||||
| Price-to-Free-Cash-Flow | 8.77 | |||||
| Price-to-Operating-Cash-Flow | 7.42 | |||||
| EV-to-EBIT | 9.01 | |||||
| EV-to-Forward-EBIT | 15.24 | |||||
| EV-to-EBITDA | 6.88 | |||||
| EV-to-Forward-EBITDA | 9.89 | |||||
| EV-to-Revenue | 2.12 | |||||
| EV-to-Forward-Revenue | 2.39 | |||||
| EV-to-FCF | 10.18 | |||||
| Price-to-Projected-FCF | 1.19 | |||||
| Price-to-DCF (Earnings Based) | 0.66 | |||||
| Price-to-DCF (FCF Based) | 0.33 | |||||
| Price-to-Median-PS-Value | 1.01 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.72 | |||||
| Earnings Yield (Greenblatt) % | 11.11 | |||||
| Forward Rate of Return (Yacktman) % | 21.98 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 9,076.832 | ||
| EPS (TTM) (A$) | 3.03 | ||
| Beta | 0.8 | ||
| Volatility % | 28.8 | ||
| 14-Day RSI | 54.88 | ||
| 14-Day ATR (A$) | 0.725159 | ||
| 20-Day SMA (A$) | 34.323 | ||
| 12-1 Month Momentum % | -18.38 | ||
| 52-Week Range (A$) | 31.96 - 46.95 | ||
| Shares Outstanding (Mil) | 480.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sonic Healthcare Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||